These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 4767576)

  • 1. Resistance of the guinea pig to pyrrolizidine alkaloid intoxication.
    Chesney CF; Allen JR
    Toxicol Appl Pharmacol; 1973 Nov; 26(3):385-92. PubMed ID: 4767576
    [No Abstract]   [Full Text] [Related]  

  • 2. Species differences in the hepatic microsomal metabolism of the pyrrolizidine alkaloid senecionine.
    Winter CK; Segall HJ; Jones AD
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1988; 90(2):429-33. PubMed ID: 2903002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting the chronic hepatotoxicity of pyrrolizidine alkaloids.
    Jago MV
    J Pathol; 1971 Sep; 105(1):1-11. PubMed ID: 5129752
    [No Abstract]   [Full Text] [Related]  

  • 4. The conversion of the pyrrolizidine alkaloid retrorsine to pyrrolic derivatives in vivo and in vitro and its acute toxicity to various animal species.
    White IN; Mattocks AR; Butler WH
    Chem Biol Interact; 1973 Apr; 6(4):207-18. PubMed ID: 4704120
    [No Abstract]   [Full Text] [Related]  

  • 5. Species differences in the in vitro metabolic activation of the hepatotoxic pyrrolizidine alkaloid clivorine.
    Lin G; Cui YY; Liu XQ; Wang ZT
    Chem Res Toxicol; 2002 Nov; 15(11):1421-8. PubMed ID: 12437333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of age on development of cor pulmonale in nonhuman primates following pyrrolizidine alkaloid intoxication.
    Allen JR; Chesney CF
    Exp Mol Pathol; 1972 Oct; 17(2):220-32. PubMed ID: 4627457
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of spironolactone treatment on the cytochrome P450-mediated metabolism of the pyrrolizidine alkaloid senecionine by hepatic microsomes from rats and guinea pigs.
    Chung WG; Buhler DR
    Toxicol Appl Pharmacol; 1994 Aug; 127(2):314-9. PubMed ID: 8048076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing pyrrolizidine (Senecio) alkaloid metabolism: species, liver sulfhydryls and rumen fermentation.
    Shull LR; Buckmaster GW; Cheeke PR
    J Anim Sci; 1976 Dec; 43(6):1247-53. PubMed ID: 1002625
    [No Abstract]   [Full Text] [Related]  

  • 9. Flavin-containing monooxygenase: a major detoxifying enzyme for the pyrrolizidine alkaloid senecionine in guinea pig tissues.
    Miranda CL; Chung W; Reed RE; Zhao X; Henderson MC; Wang JL; Williams DE; Buhler DR
    Biochem Biophys Res Commun; 1991 Jul; 178(2):546-52. PubMed ID: 1907134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major factors for the susceptibility of guinea pig to the pyrrolizidine alkaloid jacobine.
    Chung WG; Buhler DR
    Drug Metab Dispos; 1995 Nov; 23(11):1263-7. PubMed ID: 8591728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary selenium status and pyrrolizidine alkaloid metabolism in vitro by rat liver microsomes.
    Shull LR; Buckmaster GW; Cheeke PR
    Res Commun Chem Pathol Pharmacol; 1977 Jun; 17(2):337-40. PubMed ID: 877417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.
    Yang M; Ruan J; Fu PP; Lin G
    Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. trans-4-Hydroxy-2-hexenal: a reactive metabolite from the macrocyclic pyrrolizidine alkaloid senecionine.
    Segall HJ; Wilson DW; Dallas JL; Haddon WF
    Science; 1985 Aug; 229(4712):472-5. PubMed ID: 4012327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrolysis of pyrrolizidine alkaloids by guinea pig hepatic carboxylesterases.
    Dueker SR; Lamé MW; Segall HJ
    Toxicol Appl Pharmacol; 1992 Nov; 117(1):116-21. PubMed ID: 1440605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms for pyrrolizidine alkaloid activation and detoxification.
    Buhler DR; Miranda CL; Kedzierski B; Reed RL
    Adv Exp Med Biol; 1991; 283():597-603. PubMed ID: 2069028
    [No Abstract]   [Full Text] [Related]  

  • 17. Modifications of the in vitro metabolism of the hepatotoxic pyrrolizidine alkaloid, monocrotaline.
    Chesney CF; Hsu IC; Allen JR
    Res Commun Chem Pathol Pharmacol; 1974 Jul; 8(3):567-70. PubMed ID: 4853242
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxicoproteomic assessment of liver responses to acute pyrrolizidine alkaloid intoxication in rats.
    Li YH; Tai WC; Khan I; Lu C; Lu Y; Wong WY; Chan WY; Wendy Hsiao WL; Lin G
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2018 Apr; 36(2):65-83. PubMed ID: 29667502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyrrolizidine alkaloid poisoning in rats: protective effects of dietary cysteine.
    Buckmaster GW; Cheeke PR; Shull LR
    J Anim Sci; 1976 Aug; 43(2):464-73. PubMed ID: 956063
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatotoxic effects due to pyrrolizidine alkaloid N-oxides.
    Mattocks AR
    Xenobiotica; 1971; 1(4):563-5. PubMed ID: 4950811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.